Sb656933    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
299Cystic fibrosis2

299. Cystic fibrosis    [ 1,592 clinical trials,   1,539 drugs,   (DrugBank: 255 drugs),   81 drug target genes,   162 drug target pathways]
Searched query = "Cystic fibrosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
2 / 1,592 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00903201
(ClinicalTrials.gov)
September 28, 200914/5/200928 Day Repeat Dose in Cystic Fibrosis PatientsA Randomized, Double Blind, Parallel Group, Placebo Controlled 28 Day Study to Investigate the Safety, Tolerability and Pharmacodynamics of SB-656933 in Patients With Cystic Fibrosis.Cystic FibrosisDrug: SB656933;Drug: PlaceboGlaxoSmithKlineNULLCompleted18 YearsN/AAll146Phase 2United States;Canada;France;Germany;Israel
2NCT00605761
(ClinicalTrials.gov)
February 200818/1/2008SD Cystic Fibrosis StudyAn Open Label Dose Ascending, Single Dose Study to Investigate the Pharmacokinetics of SB-656933 in Subjects With Cystic Fibrosis.Cystic FibrosisDrug: SB656933GlaxoSmithKlineNULLCompleted16 YearsN/ABoth9Phase 1United States